The Australian medical community is excited with the emergence of retatrutide, a novel dual GIP and GLP-1 receptor showing significant results in early trials for addressing obesity. This therapy offers a https://auresortwear.com/2026/06/10/retatrutide-australia-my-deep-dive-into-weight-loss-treatments/